FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:839-840 September 12, 2002 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Holmberg, L. Related Article by Steineck, G. PubMed Citation

More than ever, it is important to establish definitively whether aggressive management of localized prostate cancer reduces the rate of death due to prostate cancer, because this tumor is now the second leading cause of cancer-related death among men in the United States.¹ The treatment of early prostate cancer, which has been the subject of great controversy for years, was well summarized by a question raised by Whitmore: "Is cure necessary in those in whom it may be possible, and is cure possible in those in whom it is necessary?"² In this issue of the Journal, a landmark study conducted . . . [Full Text of this Article]

This article has been cited by other articles:

• Heesakkers, R. A. M., Futterer, J. J., Hovels, A. M., van den Bosch, H. C. M., Scheenen, T. W. J., Hoogeveen, Y. L., Barentsz, J. O. (2006). Prostate Cancer Evaluated with Ferumoxtran-10-enhanced T2*-weighted MR Imaging at 1.5 and 3.0 T: Early Experience.. Radiology 239: 481-487 [Abstract] [Full Text]  
• Dodd, L. E., Simon, R., Bianco, F. J. Jr., Kattan, M. W., Scardino, P. T., D'Amico, A. V., Chen, M.-H., Catalona, W. J. (2004). PSA Velocity and Prostate Cancer. NEJM 351: 1800-1802 [Full Text]  
• Liu, P. Y., Swerdloff, R. S., Veldhuis, J. D. (2004). The Rationale, Efficacy and Safety of Androgen Therapy in Older Men: Future Research and Current Practice Recommendations. J. Clin. Endocrinol. Metab. 89: 4789-4796 [Abstract] [Full Text]  
• Bott, S R J, Birtle, A J, Taylor, C J, Kirby, R S (2003). Prostate cancer management: (1) an update on localised disease. Postgrad. Med. J. 79: 575-580 [Abstract] [Full Text]  
• Landefeld, C S. (2003). Improving Health Care for Older Persons. ANN INTERN MED 139: 421-424 [Abstract] [Full Text]  
• Sorum, P. C., Shim, J., Chasseigne, G., Bonnin-Scaon, S., Cogneau, J., Mullet, E. (2003). Why do Primary Care Physicians in the United States and France Order Prostate-Specific Antigen Tests for Asymptomatic Patients?. Med Decis Making 23: 301-313 [Abstract]  
• Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., Weissleder, R. (2003). Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer. NEJM 348: 2491-2499 [Abstract] [Full Text]  
• Talcott, J. A. (2003). Quality of Care in Prostate Cancer: Important to Start and Too Important to Stop Here. JCO 21: 1902-1903 [Full Text]  
• Smith, R. A., Cokkinides, V., Eyre, H. J. (2003). American Cancer Society Guidelines for the Early Detection of Cancer, 2003. CA Cancer J Clin 53: 27-43 [Abstract] [Full Text]